Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

302

Participants

Timeline

Start Date

September 25, 2020

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2032

Conditions
Multiple Myeloma
Interventions
DRUG

Carfilzomib Lenalidomide Dexamethasone

Isatuximab-Carfilzomib-Lenalidomide-Dexamethasone (Isa-KRd) versus Carfilzomib-Lenalidomide-Dexamethasone (KRd) in newly diagnosed multiple myeloma patients eligible for autologous stem cell transplantation

DRUG

Isatuximab Carfilzomib Lenalidomide Dexamethasone

Isatuximab-Carfilzomib-Lenalidomide-Dexamethasone (Isa-KRd) versus Carfilzomib-Lenalidomide-Dexamethasone (KRd) in newly diagnosed multiple myeloma patients eligible for autologous stem cell transplantation

Trial Locations (41)

Unknown

Het Ziekenhuisnetwerk Antwerpen - Department of Hematology, Antwerp

Fakultni Nemocnice Brno - Internal Hematology and Oncology Clinic, Brno

Fakultni Nemocnice Hradec Kralove - 4th Department of Internal Medicine, Nový Hradec Králové

Fakultni Nemocnice Ostrava - Department of Haematooncology, Ostrava

Vseobecna Fakultni Nemocnice V Praze - Internal Medicine, Hematology Clinic, Prague

Medical Center - University Of Freiburg - Department Innere Medizin Klinik für Innere Medizin I, Freiburg im Breisgau

University Medical Center Hamburg-Eppendorf - Medizinische Klinik und Polikllinik Onkologie und Knochenmarktransplantation, Haematologie, Hamburg

Klinikum rechts der Isar der TU Muenchen AöR - Innere Medizin III-Haematologie/Onkologie, München

Alexandra Hospital - Department of Clinical Therapeutics National & Kapodistrian University of Athens School of Medicine, Athens

Theageneio General Hospital - Department of Hematology Oncology, Thessaloniki

Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I G M Lancisi G Salesi-SOD Clinica Ematologica, Ancona

University Hospital Consorziale Policlinico-U.O. di Ematologia con Trapianto, Bari

Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico - U.O. di Ematologia, Bologna

Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia - UOC Ematologia, Brescia

Azienda Ospedaliera Santa Croce E Carle - S.C. Ematologia, Cuneo

Careggi University Hospital - SOD Ematologia, Florence

Azienda Ospedaliero-Universitaria Maggiore Della Carita - SDCU Ematologia, Novara

Fondazione IRCCS Policlinico San Matteo-UOC Ematologia 1, Pavia

Azienda Sanitaria Locale Di Pescara - U.O. Ematologia, Pescara

A.O.U. Città della Salute e della Scienza di Torino-U.O. Ematologia, Torino

Azienda Sanitaria Universitaria Giuliano Isontina-SC U.O.C Ematologia, Trieste

Noordwest Ziekenhuisgroep Stichting - Internal Medicine - Hematology, Alkmaar

Meander Medisch Centrum -Internal Medicine - Hematology, Amersfoort

Amsterdam-Vrije Universiteit Medical Center (VUMC), Amsterdam

Amphia Hospital-Internal Medicine - Hematology, Breda

Albert Schweitzerplaats 25, Dordrecht

Zuyderland Medisch Centrum Stichting - Internal Medicine - Hematology, Geleen

Universitair Medisch Centrum Groningen-Department of Haematology, Groningen

Medisch Centrum Leeuwarden B.V. - Oncologisch Centrum Leeuwarden (OCL) and Internal Medicine - Hematology, Leeuwarden

Sint Antonius Ziekenhuis Stichting-Internal Medicine - Hematology, Nieuwegein

ErasmusMC, Rotterdam-Department of Hematology, Rotterdam

Haga Hospital - Internal Medicine - Hematology, s-Gravenweg

Oslo University Hospital HF - Oslo myelomatosesenter, Oslo

St. Olavs Hospital HF - Department of Hematology, Trondheim

Hospital Germans Trias I Pujol - Hematology Service ICO Badalona Clinic, Badalona

Hospital Clinic De Barcelona - Myeloma and Amyloidosis Unit, Barcelona

Hospital Universitario 12 De Octubre - Hematology, Madrid

Hospital Universitario 12 De Octubre -Hematology and Hemotherapy Service, Madrid

Clinica Universidad De Navarra - Central Clinical Trials Unit, Pamplona

Hospital Universitario De Salamanca-Department of Hematology of the Salamanca University Care Complex, Salamanca

Hospital Universitario Marques De Valdecilla -Hematology and Hemotherapy Service, Santander

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

EMN Trial Office S.r.l. Impresa Sociale

OTHER

collaborator

Sanofi

INDUSTRY

collaborator

Amgen

INDUSTRY

lead

European Myeloma Network B.V.

NETWORK